Carisma Therapeutics (CARM) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$1.71

+0.02 (+1.18%)

(As of 04/18/2024 ET)

Source

Source	Headline
	Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives $9.60 Consensus PT from Brokerages americanbankingnews.com - April 14 at 1:18 AM
	Carisma Therapeutics (NASDAQ:CARM) Now Covered by BTIG Research americanbankingnews.com - April 13 at 3:40 AM
	Buy Rating Affirmed: Promising Clinical Data and Strategic Shift Bolster Carisma Therapeutics’ Outlook markets.businessinsider.com - April 12 at 5:26 AM
	Promising Future for Carisma Therapeutics’ Cancer Immunotherapy: A Buy Rating Analysis markets.businessinsider.com - April 12 at 5:26 AM
	Buy Rating Affirmed on Carisma Therapeutics Amid Promising Early Research and Pipeline Potential markets.businessinsider.com - April 11 at 5:33 PM
	Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Consensus Rating of "Buy" from Analysts marketbeat.com - April 11 at 8:18 AM
	Carisma Therapeutics (NASDAQ:CARM) Research Coverage Started at BTIG Research marketbeat.com - April 11 at 8:11 AM
	Carisma Therapeutics Welcomes New Board Member John Hohneker Amid Company Evolution msn.com - April 8 at 12:17 AM
	Q1 2024 Earnings Estimate for Carisma Therapeutics, Inc. Issued By Capital One Financial (NASDAQ:CARM) marketbeat.com - April 4 at 8:33 AM
	Wall Street Breakfast Podcast: Perma-Fix Advances In PFAS Chemical Elimination seekingalpha.com - April 4 at 7:33 AM
	Carisma Therapeutics to Present at Upcoming Conferences finance.yahoo.com - April 3 at 9:20 AM
	Carisma Therapeutics, Inc. (NASDAQ:CARM) Expected to Post FY2028 Earnings of ($1.93) Per Share marketbeat.com - April 3 at 6:46 AM
	Carisma Therapeutics (NASDAQ:CARM) Price Target Cut to $9.00 marketbeat.com - April 2 at 9:12 AM
	Penn spinout Carisma Therapeutics reducing workforce by 37% bizjournals.com - April 1 at 5:13 PM
	Carisma Therapeutics Announces Changes to its Board of Directors finance.yahoo.com - April 1 at 9:38 AM
	Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results finance.yahoo.com - April 1 at 9:38 AM
	Carisma Therapeutics, Inc. (NASDAQ:CARM) Short Interest Down 25.5% in March marketbeat.com - March 29 at 5:43 PM
	Carisma Therapeutics to Highlight Breakthroughs in Cancer Immunotherapy at AACR Annual Meeting msn.com - March 26 at 2:53 AM
	Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting finance.yahoo.com - March 21 at 8:18 PM
	Carisma Therapeutics, Inc. (NASDAQ:CARM) Sees Significant Decrease in Short Interest marketbeat.com - March 16 at 3:16 PM
	Carisma Therapeutics' CEO to Share Insights at TD Cowen Health Care Conference msn.com - March 6 at 4:53 PM
	Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference finance.yahoo.com - February 28 at 9:43 AM
	Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference prnewswire.com - February 28 at 7:30 AM
	Individual investors account for 30% of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) ownership, while institutions account for 23% finance.yahoo.com - February 27 at 7:22 AM
	Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Consensus Recommendation of "Buy" by Brokerages marketbeat.com - February 5 at 3:20 AM
	Carisma Therapeutics: New Frontiers In Cell Therapy, But Too Early To Buy In seekingalpha.com - January 7 at 8:20 AM
	Carisma Therapeutics, Inc. (NASDAQ:CARM) Short Interest Down 8.2% in December marketbeat.com - January 2 at 10:00 AM
	Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference finance.yahoo.com - December 21 at 7:31 AM
	Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Average Rating of "Buy" from Brokerages marketbeat.com - December 17 at 4:17 AM
	Innovative CAR-M Therapy Advancements Fuel Buy Rating for Carisma Therapeutics markets.businessinsider.com - December 15 at 11:50 PM
	Here's Why We're A Bit Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation finance.yahoo.com - December 9 at 8:50 AM
	Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Lantheus (LNTH) and Carisma Therapeutics (CARM) markets.businessinsider.com - December 1 at 10:34 PM
	Carisma Therapeutics Announces FDA Clearance Of IND For CT-0525 - Quick Facts markets.businessinsider.com - November 28 at 8:15 AM
	Carisma Therapeutics Gets FDA Clearance To Start Phase 1 Study Of CT-0525 In Solid Tumors markets.businessinsider.com - November 28 at 8:15 AM
	Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte finance.yahoo.com - November 28 at 8:15 AM
	Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference finance.yahoo.com - November 22 at 9:13 AM
	Benign Growth For Carisma Therapeutics, Inc. (NASDAQ:CARM) Underpins Stock's 42% Plummet finance.yahoo.com - November 11 at 9:27 AM
	Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights finance.yahoo.com - November 9 at 9:52 AM
	Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023 finance.yahoo.com - October 25 at 10:26 AM
	Capital One Initiates Coverage of Carisma Therapeutics (CARM) with Overweight Recommendation msn.com - October 5 at 8:37 AM
	The Latest Analyst Ratings for CARISMA Therapeutics markets.businessinsider.com - October 3 at 1:33 PM
	Deuterium Capital Management LLC Purchases Shares of 51,256 Carisma Therapeutics, Inc. (NASDAQ:CARM) marketbeat.com - September 8 at 10:59 AM
	What 5 Analyst Ratings Have To Say About CARISMA Therapeutics markets.businessinsider.com - September 6 at 6:15 PM
	Carisma Therapeutics to Present at Upcoming Investor Conferences finance.yahoo.com - September 5 at 3:37 PM
	Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit finance.yahoo.com - September 1 at 11:29 AM
	Wall Street Analysts Predict a 48.37% Upside in Carisma Therapeutics Inc. (CARM): Here's What You Should Know msn.com - August 23 at 3:51 PM
	Wall Street Analysts Predict a 48.37% Upside in Carisma Therapeutics Inc. (CARM): Here's What You Should Know finance.yahoo.com - August 23 at 3:51 PM
	Jump Financial LLC Buys Shares of 17,542 Carisma Therapeutics, Inc. (NASDAQ:CARM) marketbeat.com - August 14 at 4:43 AM
	Carisma Therapeutics Second Quarter 2023 Earnings: Beats Expectations finance.yahoo.com - August 13 at 5:24 PM
	HC Wainwright & Co. Maintains Carisma Therapeutics (CARM) Buy Recommendation nasdaq.com - August 11 at 11:45 PM

Get Carisma Therapeutics News Delivered to You Automatically

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

CARM Media Mentions By Week

CARM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CARM
News Sentiment
▼
0.40

0.53
▲
Average
Medical
News Sentiment

CARM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CARM Articles
This Week
▼
2

1
▲
CARM Articles
Average Week

Get Carisma Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:CARM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Carisma Therapeutics (CARM) News Today

CARM Media Mentions By Week

CARM Media Sentiment

CARM News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info